Spyre Therapeutics (NASDAQ:SYRE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Spyre Therapeutics (SYRE) operate in?

Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Spyre Therapeutics Stock (NASDAQ: SYRE) stock price, news, charts, stock research, profile.

Open	$27.78
Close	$28.43
Volume / Avg.	211.49K / 574.10K
Day Range	$27.78 - $28.55
52 Wk Range	10.42 - 47.97
Market Cap	$1.67B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	15.81%
Days to Cover	14.83

Recent News

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$27.78
Close	$28.43
Volume / Avg.	211.49K / 574.10K
Day Range	$27.78 - $28.55
52 Wk Range	10.42 - 47.97
Market Cap	$1.67B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	15.81%
Days to Cover	14.83

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Spyre Therapeutics (SYRE) stock?

You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.

View our list of the best stock brokerages

Who are Spyre Therapeutics (SYRE) competitors?

Other companies in Spyre Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Syndax Pharmaceuticals (NASDAQ:SNDX), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).

What is the forecast, or price target, for Spyre Therapeutics (SYRE) stock?

Spyre Therapeutics has a consensus price target of $48.00.

What is the current price for Spyre Therapeutics (SYRE)?

The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $28.43 last updated November 29, 2024 at 1:00 PM EST.

Does Spyre Therapeutics (SYRE) pay a dividend?

There are no upcoming dividends for Spyre Therapeutics.

When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?

Spyre Therapeutics’s Q4 earnings are confirmed for Thursday, February 27, 2025.

Is Spyre Therapeutics (SYRE) going to split?

There is no upcoming split for Spyre Therapeutics.

What sector and industry does Spyre Therapeutics (SYRE) operate in?

Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Spyre Therapeutics

Spyre Therapeutics (SYRE) Forecast